Method of treating inflammatory disorders

A method of treating a pathological syndrome by administration of activated forms of ultra-low doses of antibodies to an antigen, wherein said pathological syndrome is caused by introduction of the antigen, said activated forms are obtained by repeated consecutive dilution combined with external treatment, and said antigen is a substance or a pharmaceutical agent capable of causing intoxication and/or addiction.

A method of treating a pathological syndrome by administration of activated forms of ultra-low doses of antibodies to an antigen, wherein said activated forms are obtained by repeated consecutive dilution combined with external treatment, and said antigen is a hapten conjugated with high-molecular compound, wherein said hapten is substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of the pathological syndrome.

A method of treating a pathological syndrome by administration of activated forms of ultra-low doses of antibodies to an antigen, wherein said activated forms are obtained by repeated consecutive dilution combined with external treatment, said antigen is an antigen of a tissue or a tissue culture, and said antigen exerts influence upon the mechanisms of formation of pathological syndrome predominantly in this particular tissue.

A pharmaceutical agent for treating a pathological syndrome containing an activated form of ultra-low doses of monoclonal, polyclonal or natural antibodies, wherein said activated form is produced by repeated consecutive dilution and external treatment predominantly based on homeopathic technology, and said antigen is a substance or a drug exerting influence upon the mechanisms of formation of the pathological syndrome.